← Research library

Efficacy of Korteksin in acute period of hemispheric ischemic stroke

Comparison in people · 2018

What was studied
122 ischemic-stroke patients in four groups (30, 30, 30 and 32)
Main finding
The authors reported the greatest neurological improvement in one repeated-course group.

Best reported neurological regression · Repeated 30 mg/day group · NIHSS, mRS, Barthel, Rivermead, MMSE and MoCA used; numerical group scores absent from the abstract

Reported findings and study design

122 acute-stroke patients in four groups: 30 single-course 20 mg/day, 30 repeated-course 20 mg/day, 30 basic care, and 32 repeated-course 30 mg/day. Courses lasted ten days, with a ten-day break.

Population or model 122 ischemic-stroke patients in four groups (30, 30, 30 and 32)

Dose, route and schedule

The comparison included Cortexin 20 mg/day intramuscularly (10 mg plus 10 mg) in one course or two ten-day courses separated by ten days, basic treatment alone, and a 30 mg/day arm (10 mg three times daily) using two ten-day courses separated by ten days. All Cortexin arms were adjunctive to basic stroke treatment.

Protocol source ↗ · Indexed publication abstract

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Best reported neurological regressionRepeated 30 mg/day groupNIHSS, mRS, Barthel, Rivermead, MMSE and MoCA used; numerical group scores absent from the abstract

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Randomization and blinding are not established from the abstract.
  • Possible participant overlap with the same group’s 2016 report remains unresolved.
  • Different treatment schedules do not establish an optimal clinical regimen.

Source details

Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.

Abstract reviewed

Sources checked

Citation

Human comparative studyEnglish abstract

Belova LA, Mashin VV, Abramova VV, Slastyon EY, Belov DV. Efficacy of Korteksin in acute period of hemispheric ischemic stroke Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 30132453

Study source ↗ · DOI 10.17116/jnevro20181187130 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards